AH
Therapeutic Areas
Vincerx Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VIP236 | Metastatic Solid Tumors | Phase 1 |
| VIP943 | Relapsed/Refractory Hematologic Malignancies | Phase 1 |
| Enitociclib (VIP152) | Non-Hodgkin Lymphoma (NHL) | Phase 1 |
| BCL-2 Inhibitor Program | Oncology | Preclinical |